FRA:PYX

Schroders Competitors

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Schroders (FRA:PYX) Vs. DWS, GLJ, MLP, DBAN, ACKB, and BME

Should you be buying PYX stock or one of its competitors? Companies in the industry of "asset management" are considered alternatives and competitors to Schroders, including DWS Group GmbH & Co. KGaA (DWS), Grenke (GLJ), MLP (MLP), Deutsche Beteiligungs (DBAN), Ackermans & Van Haaren (ACKB), and BlackRock Health Sciences Trust (BME).

DWS Group GmbH & Co. KGaA (ETR:DWS) and Schroders (FRA:PYX) are both financial services companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, risk, dividends, earnings, analyst recommendations, institutional ownership and profitability.

Profitability

This table compares DWS Group GmbH & Co. KGaA and Schroders' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
DWS Group GmbH & Co. KGaAN/AN/AN/A
SchrodersN/AN/AN/A

Valuation and Earnings

This table compares DWS Group GmbH & Co. KGaA and Schroders' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
DWS Group GmbH & Co. KGaA$3.35 billion2.27$556 million€2.7813.68
SchrodersN/AN/AN/AN/AN/A

DWS Group GmbH & Co. KGaA has higher revenue and earnings than Schroders.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for DWS Group GmbH & Co. KGaA and Schroders, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
DWS Group GmbH & Co. KGaA021102.85
Schroders0000N/A

DWS Group GmbH & Co. KGaA presently has a consensus price target of €38.58, suggesting a potential upside of 1.46%.

Summary

DWS Group GmbH & Co. KGaA beats Schroders on 2 of the 2 factors compared between the two stocks.

Grenke (ETR:GLJ) and Schroders (FRA:PYX) are both financial services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, institutional ownership, valuation, earnings and dividends.

Analyst Recommendations

This is a breakdown of recent ratings and price targets for Grenke and Schroders, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Grenke12402.43
Schroders0000N/A

Grenke presently has a consensus target price of €67.14, indicating a potential upside of 110.41%.

Profitability

This table compares Grenke and Schroders' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
GrenkeN/AN/AN/A
SchrodersN/AN/AN/A

Earnings & Valuation

This table compares Grenke and Schroders' revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Grenke$537.48 million2.76$86.81 million€1.8717.09
SchrodersN/AN/AN/AN/AN/A

Grenke has higher revenue and earnings than Schroders.

Summary

Grenke beats Schroders on 2 of the 2 factors compared between the two stocks.

Schroders (FRA:PYX) and MLP (ETR:MLP) are both financial services companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, dividends, risk, institutional ownership, earnings, analyst recommendations and profitability.

Analyst Ratings

This is a summary of recent ratings for Schroders and MLP, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Schroders0000N/A
MLP01102.50

MLP has a consensus price target of €7.45, indicating a potential upside of 5.67%.

Valuation and Earnings

This table compares Schroders and MLP's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SchrodersN/AN/AN/AN/AN/A
MLP$767.30 million1.00$43.50 million€0.4017.63

MLP has higher revenue and earnings than Schroders.

Profitability

This table compares Schroders and MLP's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
SchrodersN/AN/AN/A
MLPN/AN/AN/A

Summary

MLP beats Schroders on 2 of the 2 factors compared between the two stocks.

Schroders (FRA:PYX) and Deutsche Beteiligungs (ETR:DBAN) are both financial services companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, earnings, valuation, profitability, dividends, institutional ownership and analyst recommendations.

Profitability

This table compares Schroders and Deutsche Beteiligungs' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
SchrodersN/AN/AN/A
Deutsche BeteiligungsN/AN/AN/A

Analyst Recommendations

This is a summary of recent ratings and price targets for Schroders and Deutsche Beteiligungs, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Schroders0000N/A
Deutsche Beteiligungs00503.00

Deutsche Beteiligungs has a consensus target price of €45.44, suggesting a potential upside of 12.61%.

Valuation and Earnings

This table compares Schroders and Deutsche Beteiligungs' gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SchrodersN/AN/AN/AN/AN/A
Deutsche Beteiligungs$39.80 million15.25$8.88 million€0.5968.39

Deutsche Beteiligungs has higher revenue and earnings than Schroders.

Summary

Deutsche Beteiligungs beats Schroders on 2 of the 2 factors compared between the two stocks.

Schroders (FRA:PYX) and Ackermans & Van Haaren (EBR:ACKB) are both financial services companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, dividends, profitability, risk, earnings, analyst recommendations and institutional ownership.

Profitability

This table compares Schroders and Ackermans & Van Haaren's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
SchrodersN/AN/AN/A
Ackermans & Van HaarenN/AN/AN/A

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Schroders and Ackermans & Van Haaren, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Schroders0000N/A
Ackermans & Van Haaren0000N/A

Valuation and Earnings

This table compares Schroders and Ackermans & Van Haaren's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SchrodersN/AN/AN/AN/AN/A
Ackermans & Van HaarenN/AN/AN/AN/AN/A

BlackRock Health Sciences Trust (BME:BME) and Schroders (FRA:PYX) are both financial services companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, dividends, profitability, analyst recommendations, earnings and valuation.

Valuation & Earnings

This table compares BlackRock Health Sciences Trust and Schroders' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BlackRock Health Sciences TrustN/AN/AN/AN/AN/A
SchrodersN/AN/AN/AN/AN/A

Profitability

This table compares BlackRock Health Sciences Trust and Schroders' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
BlackRock Health Sciences TrustN/AN/AN/A
SchrodersN/AN/AN/A

Analyst Ratings

This is a summary of recent ratings for BlackRock Health Sciences Trust and Schroders, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
BlackRock Health Sciences Trust0000N/A
Schroders0000N/A


Schroders Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
DWS Group GmbH & Co. KGaA logo
DWS
DWS Group GmbH & Co. KGaA
1.9$38.02flat$7.60 billion$3.35 billion13.68Analyst Report
High Trading Volume
News Coverage
Grenke logo
GLJ
Grenke
1.8$31.91flat$1.48 billion$537.48 million17.09High Trading Volume
MLP logo
MLP
MLP
1.3$7.05flat$766.76 million$767.30 million17.63
Deutsche Beteiligungs logo
DBAN
Deutsche Beteiligungs
1.5$40.35flat$607.03 million$39.80 million68.39
ACKB
Ackermans & Van Haaren
0.5N/AN/A$0.00N/A0.00News Coverage
Gap Down
BlackRock Health Sciences Trust logo
BME
BlackRock Health Sciences Trust
0.5N/AN/A$0.00N/A0.00
BlackRock Income Trust logo
BKT
BlackRock Income Trust
0.4N/AN/A$0.00N/A0.00
BNY Mellon Strategic Municipal Bond Fund logo
DSM
BNY Mellon Strategic Municipal Bond Fund
0.6N/AN/A$0.00N/A0.00
Groupe Bruxelles Lambert logo
GBLB
Groupe Bruxelles Lambert
0.7N/AN/A$0.00N/A0.00
Rand Capital logo
RAND
Rand Capital
0.4N/AN/A$0.00N/A0.00
This page was last updated on 4/13/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.